TT Electronics Reports Operational Turnaround and Strong Cash Generation in Full Year 2025 Results
TT Electronics delivers operational turnaround and strong cash flow in FY2025, with debt halved and a sharper strategy for 2026.
This article covers information on TT Electronics PLC.
LON:TTGTT Electronics FY2025: Operational Turnaround, Strong Cash, and a Sharper Strategy
TT Electronics has posted a year of two halves. 2025 was billed as a transition year, and that is exactly what the numbers show: operational fixes taking hold, cash flowing strongly, and a clearer strategic direction for 2026. Revenue fell on paper, but profitability and cash discipline improved, especially in the back half.
Headline numbers investors should know
| Metric | FY2025 | Change |
|---|---|---|
| Revenue (statutory) | £481.4 million | (7.6)% |
| Revenue (organic) | £481.4 million | (2.7)% |
| Adjusted operating profit (organic) | £37.2 million | +2.2% |
| Adjusted operating margin (organic) | 7.7% | +30 bps |
| Statutory operating loss | £(28.2) million | worse by £4.7 million |
| Free cash flow | £29.9 million | +7.9% |
| Cash conversion | 150% | +33 pts |
| Net debt (excl. leases) | £50.3 million | improved from £80.1 million |
| Leverage | 1.1x | from 1.8x |
| Book to bill ratio | 109% | from 102% |
| Adjusted EPS | 6.9p | (37.3)% |
| Dividend | None declared for 2025 | not applicable |
Quick jargon buster: “Adjusted” excludes one-off items to show underlying trading. “Book to bill” compares orders in the period with revenue; over 100% signals future growth. “Leverage” is net debt divided by EBITDA, a standard measure of balance sheet risk.
Where the growth and pressure showed up by market
- Aerospace & Defence: £152.8 million, up from £136.4 million. Europe led the charge with high-margin programmes.
- Healthcare: £107.8 million, down from £112.6 million.
- Automation & Electrification: £140.1 million, down from £161.1 million as industrial demand softened.
- Distribution: £80.7 million, down from £84.7 million as component buying normalised.
Regional performance: Europe shines, North America repairs, Asia resets
Europe delivered margin leadership
Europe posted an adjusted operating margin of 15.3% with profit up 16.9%, helped by repricing, better execution, and strong A&D programmes. The regional book to bill hit 135%, indicating solid visibility into 2026.
North America’s operational triage worked
Adjusted operating profit improved to £1.2 million from a £2.7 million loss in 2024. The turnaround was driven by actions at the Cleveland plant, which broke even on an adjusted basis in Q4, and the closure of the structurally loss-making Plano site. Plano still generated £13.0 million of revenue and c.£3.5 million of last-time-buy profit in H2, translating into a £1.2 million contribution for the year.
The sting in the tail is statutory: North America took the brunt of £41.4 million of impairments, including £37.2 million of goodwill. Painful, but non-cash.
Asia took a breather but exits stronger
Asia saw adjusted operating profit fall 24.2% to £21.6 million on lower EMS demand and the disruption of a customer transfer from Suzhou to Kuantan. The move is now complete, with Kuantan ready to ramp volumes in 2026.
Cash is king: inventory squeeze drives stellar conversion
Cash conversion hit 150% thanks to £14.8 million of underlying inventory reductions and tighter working capital control. Free cash flow rose to £29.9 million. Net debt excluding leases dropped to £50.3 million, pulling leverage down to 1.1x. That is well inside banking covenants and gives management room to manoeuvre.
The Revolving Credit Facility has been extended to June 2028 and resized to £105.0 million, which fits the slimmer footprint and lower leverage profile.
Why adjusted EPS fell even as trading improved
Adjusted EPS fell to 6.9p despite higher adjusted profit. The culprit is tax: the adjusted effective tax rate jumped to 57.1% because TT cannot currently recognise a deferred tax asset for US losses. Management notes that if recognition had been possible, adjusted EPS would have been 12.0p with a 25.4% tax rate. In short, this is an accounting headwind, not a cash one, but it still matters for reported earnings.
One-offs and clean-up costs: taking the medicine
Statutory results were dragged by £65.4 million of adjusting items, mostly non-cash. These included £41.4 million of impairments in North America, £15.2 million of restructuring (Plano closure and Cleveland support), £2.6 million of acquisition-related amortisation and £4.3 million of costs linked to the aborted Cicor approach and other M&A activity. The clear intent is to reset the base, fix underperforming assets, and focus capital where returns are strongest.
2026 game plan: divisional realignment and cost-out
- New structure: moving to Power, EMS and Components divisions to align with customers and capabilities.
- Cost reduction: c.£3 million net benefit expected in 2026, with medium-term annualised savings at roughly double that.
- Sales transformation: investment in people, pricing discipline and CRM has already lifted H2 order intake; the priority is EMS in North America and Asia.
- Components strategic review: options include a potential disposal, guided by value and market conditions.
Guidance is cautious but steady: the Board expects 2026 revenue and adjusted operating profit to be in line with company compiled consensus of £477.1 million to £487.1 million for revenue and £31.9 million to £37.6 million for adjusted operating profit.
My take: what’s good, what’s not, and why it matters
Positives
- Cash discipline is excellent. 150% cash conversion and leverage at 1.1x give strategic flexibility.
- Europe is delivering high-quality margin in attractive A&D markets, and order intake is strong.
- North American execution is improving, with Cleveland stabilising and the Plano drag removed.
- Book to bill at 109% signals rebuilding momentum after a reset year.
- Return on invested capital improved to 13.3% from 10.0%.
Watch-outs
- Statutory losses and large non-cash impairments highlight how much heavy lifting is still required in North America.
- EMS demand remains mixed, particularly in North America and Asia, which could cap near-term growth.
- No dividend for 2025. Management says it will keep this under review, but cash will first support operational progress and balance sheet strength.
- Adjusted tax rate remains elevated until US profitability is clearer; EPS is sensitive to this accounting call.
What to watch in 2026
- Cleveland’s path to sustainable profitability and order growth to lift utilisation.
- Kuantan’s volume ramp following the Suzhou transfer and broader Asia-for-Asia wins.
- Delivery of c.£3 million net cost saves and evidence of improved EMS margins.
- Outcome of the Components review, including any disposal and proceeds redeployment.
- Order intake staying above revenue, especially in A&D, to keep book to bill above 100%.
Overall, TT Electronics looks more controlled and better capitalised after a tough reset. If the operational improvements bed in and A&D strength persists, 2026 should show steadier margins and solid cash again. The equity debate now shifts from survival and clean-up to delivery and optionality.
Related
Keep reading
Investing
Chesnara half-year results 2026: OCG jumps 79% as dividend rises 6%
Chesnara lifted first-half capital generation, profit and its dividend, although acquisitions provided much of the reported growth.
JoshuaAugust 25, 2026
Investing
Rockhopper Sea Lion acceleration comes with an equity funding bill
Sea Lion's expansion could accelerate production and lift project value, but Rockhopper must raise equity to help fund the second FPSO.
JoshuaAugust 24, 2026
Investing
Tracsis delivers FY26 growth and completes £48 million Mistral Data acquisition
Tracsis expects FY26 revenue of £85.5 million and adjusted EBITDA of £13.5 million after completing its £48 million Mistral Data deal.
JoshuaAugust 24, 2026
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.